Brief: Daxor Corp Announces 49.4% Increase In Its Single-Use Diagnostic Kits Year-Over-Year And Further Acquisitions Of Its Bva-100 Blood Volume Analyzer By Leading Medical Centers Throughout U.S.
27/07/2022 13:26
July 27 (Reuters) - Daxor Corp DXR.O :
* DAXOR CORPORATION ANNOUNCES A 49.4% INCREASE IN ITS
SINGLE-USE
DIAGNOSTIC KITS YEAR-OVER-YEAR AND FURTHER ACQUISITIONS OF ITS
BVA-100® BLOOD VOLUME ANALYZER BY LEADING MEDICAL CENTERS
THROUGHOUT THE U.S.
Source text for Eikon: ID:nGNX99NQFd
Further company coverage: DXR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Daxor
See all newsNASDAQ RESUMED AT 02:03 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:58 PM
Brief: Daxor Corp Reaffirms Focus On Blood Volume Analysis Technology
Brief: Daxor Corporation Submits 510(K) To FDA For Next-Generation Blood Volume Analyzer
Brief: Daxor Corporation Streamlines Regulatory Strategy For Groundbreaking Diagnostic Device